Skip To Content

IHE Methodology Forum



Prioritizing Methodological Research in Evaluation of Health Technologies



September 23 - 24th, 2010
Edmonton, Alberta, Canada
The Westin Edmonton


Chair: Dr. Michael Drummond, University of York
Program Development Leads: Dr. Deborah Marshall, University of Calgary & Dr. Michael Drummond, University of York.

 

Forum Overview:

Advancements in methodological approaches in the evaluation of health technologies are important for ensuring ongoing improvement in the comprehensiveness and quality of assessments. On September 23 and 24th, 2010, The Institute of Health Economics (IHE) conducting an invitational methodology forum addressing the economic evaluation of medicines in Canada. Delegates from academia, government, industry and other stakeholders involved in the production and use of evidence were brought together to discuss methodological challenges in evaluation of technologies and to identify priorities for research methods development in Canada. A report summarizing the proceedings is available at the link below:

Summary Report
 

IHE Methodology Forum Agenda:

Thursday, September 23, 2010

1500 - 1515       Welcome and Opening Remarks

1515 - 1530       Overview of the Methodology Forum: Prioritizing Methodological Research in Evaluation of 
                          Health Technologies

                          Michael Drummond, Forum Moderator; Professor of Health Economics, University of York
                          Presentation

1530 - 1600       Identifying NICE's Methodological Research Priorities: a survey of priorities
                          Mark Sculpher, University of York
                          Presentation

1600 - 1610       International and Stakeholder Perspectives
                          Chris Henshall, Chair, Health Technology Assessment International Policy Forum
                          Presentation

1610 - 1630       Discussion

1630 - 1645       Break

1645 - 1745       Health Policy Panel Session
                          Moderator: Michael Drummond, University of York
                          Brian O'Rourke, Canadian Agency for Drugs and Technology in Health
                          Robert Petersen, Chair, Canadian Expert Drug Advisory Committee and Executive Director of the
                          Drug Safety and Effectiveness Network
                          Jean Pruneau, Health Canada
                          Newell McElwee, Merck

1745 - 1830       Reception

1830 - 2030       Dinner

 

Friday, September 24, 2010

0700 - 0800       Continental Breakfast

0800 - 0815       Overview of the Agenda
                          Michael Drummond, Forum Moderator; Professor of Health Economics, University of York

0815 - 0930       Methodological Challenge #1 - Data quality and the development of national costing panels 
                           to better utilize administrative data
                          Chair and Discussant: Tammy Clifford, Canadian Agency for Drugs and Technologies in Health

                          Presenters:
                          Larry Svenson, Alberta Health and Wellness
                          Presentation
                          Mike Gaucher, Canadian Institute for Health Information
                          Philip Jacobs, University of Alberta
                          Presentation

0930 - 1000       Methodological Challenge #2 - Incorporating routine measurement of patient reported 
                          outcomes

                          Chair and Discussant: Herb Emery, University of Calgary

                          Presenter:
                          Stirling Bryan, University of British Columbia and Vancouver Coastal Health Authority
                          Presentation

1000 - 1030       Refreshment Break

1030 - 1115       Methodological Challenge #3 - How to incorporate multi-criteria decision frameworks into 
                          economic evaluations and decision making

                          Chair and Discussant: Farzad Ali, Pfizer

                          Presenters:
                          Stuart Peacock, British Columbia Cancer Agency
                          Presentation
                          Deborah Marshall, University of Calgary
                          Presentation

1115 - 1145       Methodological Challenge #4 - Approaches to mitigating against methodologic bias in         
                          economic evaluations

                          Chair and Discussant: Karen Lee, Canadian Agency for Drugs and Technologies in Health

                          Presenter:
                          Braden Manns, University of Calgary
                          Presentation

1145 - 1300       Lunch

1300 - 1400       Methodological Challenge #5 - How to incorporate a broader health system and societal 
                          perspective in evaluation including the value of innovation
                          Chair and Discussant: Mark Sculpher, University of York
                          Presentation

                          Presenters:
                          Marc Berger, Eli Lilly
                          Presentation
                          Don Husereau, Canadian Agency for Drugs and Technologies in Health

1400 - 1515       Prioritization Panel Discussion and Debate
                          Moderator: Michael Drummond
                          Panel Members:
                          Tom Noseworthy, University of Calgary
                          Kathy Kovac Burns, Health Sciences Council, University of Alberta
                          Terri Jackson, University of Queensland/University of Alberta
                          Nigel Rawson, GSK

1515 - 1530       Refreshment Break

1530 - 1545       Closing Comments and Next Steps
                          Michael Drummond, Forum Moderator; Professor of Health Economics, University of York
                          Presentation


 Final Program



The event was made possible by support from: Institute of Health Economics, Canadian Agency for Drugs and Technologies in Health, National Institute for Clinical Excellence, IHE Board member organizations: Merck, Pfizer, Eli Lilly, Astra Zeneca, GlaxoSmithKline and Alberta Health and Wellness